Table IV.
Clinical characteristics of patients with asSpA according to the gender with mean values of laboratory findings
| Men | Women p – t-Student | |
|---|---|---|
| Number of patients | 51 | 14 |
| Age, mean (SD) years | 44 (SD 12) | 47 (SD 11) 0.82 |
| Group without relapse | 11/51 (21%) | 3/14 (21%) |
| Qualification parameters: | ||
| BASDAI | ||
| group with relapse | 6.0 | 6.5 0.22 |
| group without relapse | 6.4 | 7.8 |
| VAS back pain | ||
| group with relapse | 72 mm | 86 mm 0.002 |
| group without relapse | 73 mm | 82 mm |
| ESR (mm/h) | ||
| group with relapse | 29 | 41 0.4 |
| group without relapse | 18 | 17 |
| CRP (mg/l) | ||
| group with relapse | 6 | 6.5 0.76 |
| group without relapse | 12.8 | 2.6 |
| Hb (g/dl) | ||
| group with relapse | 13.7 | 11.7 0.007 |
| group without relapse | 13.4 | 14.3 |
| WBC count × 109/l | ||
| group with relapse | 7.9 | 6.8 0.08 |
| group without relapse | 7.2 | 5.6 |
| PLT count × 109/l | ||
| group with relapse | 324 | 333 0.94 |
| group without relapse | 302 | 237 |
ESR – erythrocyte sedimentation rate; CRP – C-reactive protein; WBC – white blood cells count; PLT – platelets; Hb – haemoglobin level; BASDAI – Bath Ankylosing Spondylitis Disease Activity Index; VAS low back pain – visual analogue scale for low back pain; Group 1 – group of patients with relapse after LDA; Group 2 – group of patients with remission without relapse after LDA ≥ 6 months; Group 3 – group with no remission; SD – standard deviation